Internal Medicine · Traverse City, MI
NPI
1699781658
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1221 Sixth St Ste 206
Traverse City, MI, 49684
Phone (231) 935-5090
Groups this clinician bills Medicare through
Medicare paid, 2024
$68K
733 services
Medicare patients, 2024
136
Average age 73
Drug cost, 2024
$1.0M
684 prescriptions
Company payments, 2025
$190
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Dennis S Sula was code 99233 (hospital e&m - subsequent), 441 times for 96 patients. In total Dennis S Sula billed 733 services in 11 codes, and Medicare paid $68K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-12-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 441 | 96 | $97.38 | $43K |
| 99232 Hospital E&M - Subsequent | Facility | 91 | 71 | $64.98 | $5,913 |
| 99223 Hospital E&M - Initial | Facility | 81 | 77 | $141.58 | $11K |
| 99213 Office E&M - Established | Office | 50 | 35 | $59.43 | $2,971 |
| 99214 Office E&M - Established | Facility | 34 | 29 | $73.05 | $2,484 |
By year: 2022 $74K for 885 services; 2023 $77K for 870 services; 2024 $68K for 733 services.
Medicare prescription drug claims, 2024
In 2024, the drug Dennis S Sula prescribed most often to Medicare patients was Cephalexin, with 159 prescriptions and refills. In total Dennis S Sula wrote 684 Medicare prescriptions that cost $1.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Cephalexin Generic | 159 | 178 | 31 | $2,206 |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 126 | 126 | 12 | $510K |
| Amoxicillin Generic | 58 | 68 | 12 | $578 |
| Ciprofloxacin Hcl Generic | 39 | 39 | Under 11 | $220 |
| Ceftriaxone Ceftriaxone Sodium | 31 | 31 | Under 11 | $2,123 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 23 | 23 | Under 11 | $43.41 |
| Doxycycline Hyclate Generic | 21 | 29 | 13 | $273 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 18 | 18 | 17 | $288 |
| Penicillin G Potassium Generic | 17 | 17 | Under 11 | $6,228 |
| Fluconazole Generic | 17 | 19 | Under 11 | $1,047 |
| Metronidazole Generic | 14 | 15 | Under 11 | $285 |
| Epclusa Sofosbuvir/Velpatasvir | 13 | 13 | Under 11 | $302K |
| Piperacillin-Tazobactam Piperacillin Sodium/Tazobactam | 13 | 13 | Under 11 | $2,784 |
| Dovato Dolutegravir Sodium/Lamivudine | 12 | 12 | Under 11 | $33K |
| Cefuroxime Cefuroxime Axetil | 12 | 12 | Under 11 | $315 |
Brand drugs: 180 claims; generic drugs: 504 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Dennis S Sula $190 ($190 in general payments such as food, travel and fees) from 2 companies. The largest payer was Abbvie Inc. with $118.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.